Welcome to our dedicated page for Maxlinear SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MaxLinear, Inc.'s SEC filings document its public-company disclosures as a semiconductor issuer focused on RF, analog, digital and mixed-signal integrated circuits. Recent 8-K filings cover quarterly operating results, material agreements, credit-facility amendments, share repurchase authorization and governance changes.
Proxy materials describe board structure, director elections, committee service, executive compensation, equity awards and shareholder voting matters. The filing record also reflects capital-structure items tied to common stock, revolving credit arrangements, subsidiary participation in financing agreements and the risk and governance disclosures associated with MaxLinear’s operating business.
MaxLinear, Inc. director Albert J. Moyer reported a routine compensation-related share exercise followed by a sale. On May 1, 2026, 15,741 restricted stock units vested, and he acquired the same number of common shares through a derivative exercise.
On May 4, 2026, he conducted an open-market sale of 15,741 common shares at $78.00 per share. After these transactions, Moyer directly held 72,793 shares of MaxLinear common stock.
MAXLINEAR, INC director Daniel A. Artusi reported both an equity award vesting and a share sale. On May 1, 2026, 15,741 restricted stock units vested and were converted into the same number of common shares at a $0.00 exercise price. On May 4, 2026, he completed an open-market sale of 10,500 common shares at a weighted average price of $78.6408 per share, across a price range of $78.60 to $78.76. Following these transactions, he holds 17,382 common shares directly.
MXL reporting person Theodore Tewksbury filed a Form 144 indicating an intended sale of 3,935 shares of Common Stock, designated as Restricted Stock, with an execution date listed as 05/01/2026. The filing also reports 2,790 shares sold during the past three months for $219,475.35.
MAXLINEAR, INC Corporate Controller & PAO Connie H. Kwong reported an open-market sale of 4,118 shares of Common Stock at $58.00 per share on April 29, 2026. Following this sale, she directly holds 48,947 shares of MaxLinear common stock.
Morgan Stanley Smith Barney LLC Executive Financial Services filed a Form 144 notice related to proposed sales of Common Stock for filer activities on 04/29/2026. The filing lists multiple blocks of restricted stock grants with stated share counts and shows a sale of 15,050 shares on 04/27/2026 for $771,948.29.
MaxLinear, Inc. executive Connie H. Kwong, the Corporate Controller & PAO, reported an open-market sale of 15,050 shares of Common Stock. The weighted average sale price was $51.2922 per share, and she now directly holds 53,065 shares following this transaction.